TopFunds

Johnson & Johnson

NYSE: JNJ

Stock price

253.04 USD

(+Infinity%) NaN day

Drug Manufacturers - General

Financial Performance

Share

5Y price score: 69

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 139.2%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    162.7

    52-week range

    269.4

    253.04

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    2.5 %

    Dividend Yield TTM

    2.1 %

    Market cap $

    $ 609,123

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    29.3

    Price / Book TTM

    7.6

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    0.3

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    58.4 %

    64.4 %

    139.2 %

    Free cash flow per share growth

    (0.7) %

    7.3 %

    44.2 %

    Earnings per share growth

    90.5 %

    100.2 %

    101.3 %

    Founded: 1,886

    Employees: 138,100

    Business Summary:Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    20252024202320222021201920182017

    Johnson & Johnson — Financial Overview, Stock Price, Market Cap

    Johnson & Johnson is a company. Founded in 1886. As of July 20, 2026, the company's market capitalization is $609122948800 with a current stock price of $253.04.